Clinuvel Pharmaceuticals Ltd (CLVLF) community

CLVLFOTCAmerican Depositary ReceiptsFiscal year ends June 30Also trades as CUVL

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 30, 2026Score 9/30

$5.05−0.33 (-6.13%)

Close on Oct 19, 2026Market cap $254.66MP/E 11.0Yield –

Community

Notes and questions about Clinuvel Pharmaceuticals from other investors

No posts about CLVLF yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Clinuvel Pharmaceuticals's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CLVLF.

Compare: CLVLF vs VRDN · CLVLF vs BFRI · CLVLF vs PLX · CLVLF vs FBIO · CLVLF vs ETON

Revenue growth5.2% · median 17.8%

Gross margin82.9% · median 69.2%

Operating margin43.4% · median -14.2%

Net margin36.0% · median 23.5%

Company	Revenue	Growth
ETON	$141.06M	+100.6%
PLX	$80.62M	+30.1%
FBIO	$68.47M	+15.5%
CLVLF	$64.32M	+5.2%
BFRI	$46.18M	+17.8%
VRDN	$26.31M	-62.8%

Company

Exchange: OTC
Industry: American Depositary Receipts
Fiscal year ends: June 30
Employees: 50
SEC CIK: 1290877

Advertisement
300 × 250

See a number that looks wrong?